Connect with us

Hi, what are you looking for?

Stocks

DP Trading Room: Is Broadcom (AVGO) the New NVIDA (NVDA)?

Today Erin looks at the Broadcom (AVGO) chart and compares it to the NVIDIA (NVDA) chart. She shows us the differences between the two and tells you whether she believes AVGO will be the new NVDA, meaning it will perform as NVDA used to perform with a concerted move up nearly everyday.

Carl analyzes the market and gives you all you need to know going into this trading week. He discusses his thoughts on where the market may be headed in January. Can the rally continue?

After the market overview, Carl covers the Magnificent Seven in the short term and the intermediate term by looking at both the daily and weekly charts for each.

The pair then answer questions posed by audience on OBV construction and a discussion of how we use the Bias Table for short-term analysis. Currently the table is flipping bearish.

Erin covers sector rotation and gives us two sectors to watch moving into this week. Two sectors are in decline but they have both reached very interesting levels of support that could precede an upside reversal.

Finally Erin covers viewers symbol requests.

If you’d like to join us in the free DP Trading Room on Mondays at Noon ET, sign up at this link: https://zoom.us/webinar/register/WN_D6iAp-C1S6SebVpQIYcC6g#/registration

Don’t forget you can get a free two week trial of any of our subscriptions by using coupon code: DPTRIAL2 at checkout!

01:06 DP Signal Tables

04:22 Semiconductor Chart

06:39 Market Overview

17:27 Magnificent Seven

23:46 Questions

30:52 Broadcom v. NVIDIA

38:16 Sector Rotation

42:04 Symbol Requests


The DP Alert: Your First Stop to a Great Trade!

Before you trade any stock or ETF, you need to know the trend and condition of the market. The DP Alert gives you all you need to know with an executive summary of the market’s current trend and condition. It not only covers the market! We look at Bitcoin, Yields, Bonds, Gold, the Dollar, Gold Miners and Crude Oil every market day! Only $50/month! Or, use our free trial to try it out for two weeks using coupon code: DPTRIAL2. Click HERE to subscribe NOW!


Learn more about DecisionPoint.com:


Watch the latest episode of the DecisionPointTrading Room on DP’s YouTube channel here!


Try us out for two weeks with a trial subscription!

Use coupon code: DPTRIAL2 Subscribe HERE!


Technical Analysis is a windsock, not a crystal ball. –Carl Swenlin


(c) Copyright 2024 DecisionPoint.com


Disclaimer: This blog is for educational purposes only and should not be construed as financial advice. The ideas and strategies should never be used without first assessing your own personal and financial situation, or without consulting a financial professional. Any opinions expressed herein are solely those of the author, and do not in any way represent the views or opinions of any other person or entity.

DecisionPoint is not a registered investment advisor. Investment and trading decisions are solely your responsibility. DecisionPoint newsletters, blogs or website materials should NOT be interpreted as a recommendation or solicitation to buy or sell any security or to take any specific action.


Helpful DecisionPoint Links:

Trend Models

Price Momentum Oscillator (PMO)

On Balance Volume

Swenlin Trading Oscillators (STO-B and STO-V)

ITBM and ITVM

SCTR Ranking

Bear Market Rules


    You May Also Like

    Sports

    Lots of love shared from one legendary Minnesota Vikings wide receiver to another. The NFL community has showed an outpouring of support for Hall...

    Business

    Startup basketball league Unrivaled announced on Monday it’s closed a Series A funding round, raising an additional $28 million before its inaugural season. “Our players...

    Politics

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    Business

    McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company’s consulting work advising Purdue Pharma on...

    Disclaimer: americanbrokersalliance.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 americanbrokersalliance.com | All Rights Reserved